1,25-Dihydroxyvitamin D3 is a positive regulator for the two anti- encephalitogenic cytokines TGF-β1 and IL-4

Journal of Immunology

Volumn 160, Issue 11, 1998, Pages 5314-5319

  Cantorna, Margherita T ^a   Woodward, William D ^a,b   Hayes, Colleen E ^a   DeLuca, Hector F ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA1;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RELAPSE; VITAMIN METABOLISM;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; CALCITRIOL; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INTERFERON TYPE II; INTERLEUKIN-4; LYMPH NODES; LYMPHOCYTE COUNT; MALE; MICE; MICE, INBRED C57BL; SPINAL CORD; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032103001     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Acheson, E. D., C. A. Bachrach, and F. M. Wright. 1960. Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables. Acta Psychiatry Neurol. Scand. 35(Suppl. 147):132.
2. Norman, J. E., J. F. Kurtzke, and G. W. Beebe. 1983. Epidemiology of multiple sclerosis in U.S. veterans. II. Latitude, climate and the risk of multiple sclerosis. J. Chronic Dis. 36:551.
3. Butcher, P. J. 1986. Milk consumption and multiple sclerosis: an etiological hypothesis, Med. Hypotheses 19:169.
4. Goldberg, P. 1974. Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence: sunlight, dietary factors and epidemiology. Int. J. Environ. Stud. 6:19.
5. Goldberg, P. 1974. Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence: biochemical and genetic factors. Int. J. Environ. Stud. 6:121.
6. Schwartz, G. G. 1992. Multiple sclerosis and prostate cancer: what do their similar geographies suggest? Neuroepidemiology 11:244.
7. 3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc. Natl. Acad. Sci. USA 93:7862.
8. Holda, J. H., and R. H Swanborg. 1982. Autoimmune effector cells. II. Transfer of experimental allergic encephalomyelitis with a subset of T lymphocytes. Eur. J. Immunol. 12:342.
9. Powell, M. B., D. Mitchell, J. Lederman, J. Buckmeier, S. S. Zamvil, M. Graham, N. H. Ruddle, and L. Steinman. 1990. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int. Immunol. 2:539.
10. Renno, T., M. Krakowski, C. Piccirillo, J. Lin, and T. Owens. 1995. TNF-α expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis: regulation by Th1 cytokines, J. Immunol 154:944.
11. Correale, J., W. Gilmore, M. McMillan, S. Li, K. McCarthy, T. Le, and L. P. Weiner. 1995. Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis. J. Immunol. 154:2959.
12. Ruddle, N. H., C. M. Bergman, K. M. McGralh, E. G. Lingenheld, M. L. Grunnet, S. J. Padula, and R. B. Clark. 1990. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1193.
13. Willenborg, D. O., S. Fordham, C. C. A. Bernard, W. B. Cowden, and I. A. Ramshaw. 1996. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyle glycoprotein-induced autoimmune encephalomyelitis. J. Immunol 157:3223.
14. Feber, I. A., S. Brocke, C. Taylor-Edwards, W. Ridgway, C. Dinisco, L. Steinman, D. Dalton, and C. G. Fathman. 1996. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156:5.
15. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16:34.
16. Racke, M. K., S. Dhib-Jalbut, B. Cannella, P. S. Alert, C. S. Raine, and D. E. McFarlin. 1991. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-βl. J. Immunol. 146:3012.
17. Racke, M. K., B. Cannella, P. Albert, M. Sporn, C. S. Raine, and D. E. McFarlin. 1992. Evidence of endogenous regulatory function of transforming growth factor-β1 in experimental allergic encephalomyelitis. Int. Immunol 4:615.
18. Raine, C S. 1984. Biology of disease: analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab. Invest. 50:608.
19. 3. J. Cell Biochem. 49:26.
20. Saggese, G., G. Federico, M. Balestri, and A. Toniolo. 1989. Calcitriol inhibits the PHA-induced production of IL-2 and IFN-γ and the proliferation of human peripheral blood leukocytes while enhancing the surface expression of HLA class II molecules. J. Endocrinol. Invest. 12:329.
21. 3 (calcitriol). J. Clin. Invest. 74:1451.
22. Clatch, R. J., S. D. Miller, R. Metzner, M. C. Dal Canto, and H. L. Lipton. 1990. Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology 176:244.
23. Wiiliamson, J. S. P., K. C. Sykes, and S. A. Stohlman. 1991. Characterization of brain-infiltrating mononuclear cells during infection with mouse hepatitis virus strain JHM. J. Neuroimmunol. 32:199.
24. Cantorna, M. T., F. E. Nashold, and C. E. Hayes. 1995. Vitamin A deficiency results in a priming environment conducive for Th1 cell development. Eur. J. Immunol. 215:1673.
25. Cantoma, M. T., F. E. Nashold, and C. E. Hayes. 1994. In vitamin A deficiency multiple mechanisms establish a regulatory Th cell imbalance with excess Th1 and insufficient Th2 function. J. Immunol. 152:1515.
26. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.
27. Siebert, P. D., and J. W. Larrick. 1992. Competitive PCR. Nature 359:557.
28. Siebert, P. D., and J. W. Larrick. 1993. PCR MIMICS: competitive DNA fragments for use as internal standards in quantitative PCR. BioTechniques 14:244.
29. Danielpour, D. L., L. Dart, K. C. Flanders, A. B. Roberts, and M. B. Sporn. 1989. Immunodetection and quantitation of the two forms of transforming growth factor-β (TGF-β) and TGF-β2) secreted by cells in culture. J. Cell Physiol. 138:79.
30. Letterio, J. J., and A. B. Roberts. 1996. Transforming growth factor-β1-deficient mice: identification of isoform-specific activities in vivo. J. Leukocyte Biol 59:769.
31. Santambrogio, L., G. M. Hochwald, B. Saxena, C. H. Leu, J. E. Martz, J. A. Carlino, N. H. Ruddle, M. A. Palladino, L. I. Gold, and G. J. Thorbecke. Studies on the mechanisms by which transforming growth factor-β (TGF-β) protects against allergic encephalomyelitis: antagonism between TGF-β and tumor necrosis factor. J. Immunol. 151:1116.
32. 3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J. Clin. Endocrinol Metab. 570:1308.
33. 3 receptors in human leukocytes. Science 221:1181.